Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4326
Hamilton Lane
HLNE
$5.56B
| $3.24M | ﹤0.01% |
41,547
-55,132
| -57% | -$4M |
|
|
MRSH
4327
PUT
Marsh
MRSH
$87.9B
| $3.24M | ﹤0.01% |
27,700
-37,300
| -57% | -$4.24M |
|
4328
Vanguard Total Corporate Bond ETF
VTC
$1.7B
| $3.24M | ﹤0.01% |
34,376
+14,262
| +71% | +$1.33M |
|
4329
PUT
Arcturus Therapeutics
ARCT
$231M
| $3.24M | ﹤0.01% |
74,600
+30,200
| +68% | +$2.05M |
|
4330
CALL
Old National Bancorp
ONB
$10.4B
| $3.24M | ﹤0.01% |
195,400
+10,000
| +5% | +$153K |
|
|
SNBR
4331
DELISTED
Sleep Number
SNBR
| $3.24M | ﹤0.01% |
39,528
-5,430
| -12% | -$377K |
|
4332
PUT
Caleres
CAL
$446M
| $3.23M | ﹤0.01% |
206,700
+157,400
| +319% | +$1.76M |
|
4333
Tanger
SKT
$4.41B
| $3.23M | ﹤0.01% |
324,827
+23,450
| +8% | +$198K |
|
4334
SSR Mining
SSRM
$6.68B
| $3.23M | ﹤0.01% |
160,887
+11,879
| +8% | +$226K |
|
4335
CALL
e.l.f. Beauty
ELF
$5.53B
| $3.23M | ﹤0.01% |
128,400
+105,600
| +463% | +$2.27M |
|
|
EBIX
4336
DELISTED
Ebix Inc
EBIX
| $3.23M | ﹤0.01% |
85,120
-550
| -0.6% | -$15.5K |
|
4337
Pearson
PSO
$9.72B
| $3.23M | ﹤0.01% |
351,710
-140,427
| -29% | -$1.12M |
|
4338
PUT
Direxion Daily 20+ Year Treasury Bear 3X ETF
TMV
$196M
| $3.23M | ﹤0.01% |
239,120
+68,320
| +40% | +$921K |
|
|
MLAC
4339
DELISTED
Malacca Straits Acquisition Company Limited Class A Ordinary Shares
MLAC
| $3.23M | ﹤0.01% |
+325,563
| New | +$3.19M |
|
4340
Steris
STE
$22.4B
| $3.22M | ﹤0.01% |
16,985
-3,188
| -16% | -$595K |
|
|
PPL
4341
PPL Corp
PPL
$27B
| $3.22M | ﹤0.01% |
+114,119
| New | +$3.24M |
|
4342
CALL
Transocean
RIG
$6.56B
| $3.22M | ﹤0.01% |
1,393,200
-987,300
| -41% | -$1.45M |
|
|
WLL
4343
DELISTED
Whiting Petroleum Corporation
WLL
| $3.22M | ﹤0.01% |
128,701
-947,502
| -88% | -$19M |
|
4344
ProShares Ultra Dow30
DDM
$577M
| $3.22M | ﹤0.01% |
113,906
-138,744
| -55% | -$3.56M |
|
4345
iShares MSCI Ireland ETF
EIRL
$78.9M
| $3.21M | ﹤0.01% |
63,642
+24,409
| +62% | +$1.12M |
|
|
ADVM
4346
DELISTED
Adverum Biotechnologies
ADVM
| $3.21M | ﹤0.01% |
29,622
-12,632
| -30% | -$1.56M |
|
4347
iShares ESG Aware MSCI EM ETF
ESGE
$6.91B
| $3.21M | ﹤0.01% |
+76,493
| New | +$2.98M |
|
4348
Fortuna Silver Mines
FSM
$3.19B
| $3.21M | ﹤0.01% |
389,603
+197,928
| +103% | +$1.37M |
|
|
GTHX
4349
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $3.21M | ﹤0.01% |
178,380
-82,384
| -32% | -$1.23M |
|
4350
CALL
ProShares Ultra Russell2000
UWM
$266M
| $3.21M | ﹤0.01% |
71,600
-8,400
| -11% | -$303K |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,988 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.